secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jade Biosciences, Inc. (JBIO)
CIK:        0001798749
Form:       8-K
Filed at:   2025-04-29T23:59:59+00:00
Accession:  0001193125-25-103761
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jade Biosciences provides updated corporate presentation; no material new details disclosed
--------------------------------------------------------------------------------

- Company changed name from Aerovate Therapeutics to Jade Biosciences, effective prior to this filing; trades under ticker JBIO on Nasdaq.
- Updated corporate presentation posted on company website on April 29, 2025; no financial or operational updates provided in the 8-K or exhibit.
- Presentation appears to be a Company Overview slide with disclaimers; no new specific data (revenue, pipeline, guidance) disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1798749/000119312525103761/0001193125-25-103761-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1798749/000119312525103761/d938753d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-103761

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer